[Influence of obesity on urological malignancies]
- PMID: 23975219
- DOI: 10.1007/s00120-013-3317-z
[Influence of obesity on urological malignancies]
Abstract
Background: Overweight presents a growing problem in our society; therefore, there is an increasing interest to understand the influence of obesity on urological forms of cancer.
Aim: In prostate cancer the development of a more aggressive phenotype seems to correlate with obesity. In renal cell cancer (RCC) obesity is both, a risk factor for occurrence -and is also associated with an improved tumour-specific survival in patients with organ-confined disease following kidney surgery as well as overall survival of patients with advanced disease receiving VEGF(R)-targeted treatment. In contrast, even though an association between body mass index (BMI) and bladder cancer has been described the role of obesity in bladder cancer remains largely unclear as published data are contradictory.
Results: An update on currently available data focusing on the relationship between obesity and genitourinary malignancies is given in this review; however, basic research which is necessary to define the biological and metabolic effects associated with obesity and which might affect the development and progression of urological cancers, is indicated.
Similar articles
-
Prognostic Role of C-Reactive Protein In Urological Cancers: A Meta-Analysis.Sci Rep. 2015 Aug 3;5:12733. doi: 10.1038/srep12733. Sci Rep. 2015. PMID: 26235332 Free PMC article.
-
Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.Lancet Oncol. 2020 Feb;21(2):283-293. doi: 10.1016/S1470-2045(19)30797-1. Epub 2019 Dec 20. Lancet Oncol. 2020. PMID: 31870811 Free PMC article.
-
Autoimmune disease and subsequent urological cancer.J Urol. 2013 Jun;189(6):2262-8. doi: 10.1016/j.juro.2012.12.014. Epub 2012 Dec 8. J Urol. 2013. PMID: 23228387
-
The impact of obesity in urology.Urol Clin North Am. 2004 May;31(2):275-87. doi: 10.1016/j.ucl.2004.01.005. Urol Clin North Am. 2004. PMID: 15123407 Review.
-
Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes.Int J Urol. 2013 Feb;20(2):161-71. doi: 10.1111/j.1442-2042.2012.03121.x. Epub 2012 Aug 16. Int J Urol. 2013. PMID: 22897628 Review.
Cited by
-
The Sirenic Links between Diabetes, Obesity, and Bladder Cancer.Int J Mol Sci. 2021 Oct 15;22(20):11150. doi: 10.3390/ijms222011150. Int J Mol Sci. 2021. PMID: 34681810 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical